¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"maximum heart rate"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® rheumatic heart disease ÇÑ±Û ·ù¸¶Æ¼½º½ÉÀ庴
¼³¸í   
  »ç½½¾Ë±Õ°¨¿° ÈÄ »ý±â´Â ½ÉÀåÆÇ¸·º´ÀÌ´Ù. ¿øÀÎÀº A±º -¿ëÇ÷»ç½½¾Ë¿¡ ÀÇÇÑ Àεο°ÈÄ ÀÏÁ¾ÀÇ ¸é¿ª¹ÝÀÀÀ¸·Î ¹ßº´ÇÑ´Ù.
  
  Áø´ÜÀº Á¸ÀÇ ±âÁØ¿¡ ÀÇÇÑ´Ù.
  
  (1) ÁÖ¿ä±âÁØÀº °üÀý¿° ½ÉÀå¿°(½ÉÀåºñ´ë, ½ÉÀåÀâÀ½, ½ÉÀå±â´É»ó½Ç µî) ¹«µµÁõ: ¹«´çÀÌ ÃãÀ» Ãߴ °Í °°Àº ÇൿÀÇ ¹ßÀÛÁõ¼¼. ¿¬º¯È«¹Ý: »¡°£ Å׵θ®¸¦ °¡Áø ÇǺκ´º¯Àº ÇÇÇϰáÀý(subcutaneous nodule): ÇǺΠ¹Ø¿¡ »ý±ä °áÀý,
  
  (2)Âü°í ±âÁØÀº ¿­, °üÀýÅë, EKG»ó PR¿¬Àå: ½ÉÀüµµ ¼Ò°ß ±Þ¼º±â ¹ÝÀÀ¹°Áú(¿¹: ESR, CRP)ÀÇ »ó½Â, ·ù¸¶Æ¼½º¿­
  
  Ä¡·á´Â Æä´Ï½Ç¸°À¸·Î Ä¡·áÇÏ°í ½ÉÀåÀÇ ÈÄÀ¯Áõ ¶ÇÇÑ Æä´Ï½Ç¸°À¸·Î ¿¹¹æÇÑ´Ù.
¿µ¹® congenital heart disease ÇÑ±Û ¼±Ãµ½ÉÀ庴
¼³¸í   
  ¼±ÃµÀûÀ¸·Î ½ÉÀåÀÇ ±¸Á¶¿¡ ÀÌ»óÀÌ Àִ º´.
¿µ¹® heart ÇÑ±Û ½ÉÀå
¼³¸í   
  ½ÉÀåÀº °¡½¿ÀÇ Áß¾Ó¿¡ À§Ä¡Çϸ砿À¸¥Âʰú ¿ÞÂʹÝÀ¸·Î ³ª´­ ¼ö ÀÖ´Ù. °¢°¢Àº Á¤¸Æ¿¡¼­ Çǰ¡ µé¾î¿À´Â ¹æ°ú µ¿¸ÆÀ¸·Î ÇǸ¦ ³»º¸³»´Â ½ÇÀÌ ÀÖ´Ù. ½ÉÀåÀº Á¤Áß¾Ó¼±¿¡¼­ ¿ÞÂÊ¿¡ ³õ¿© ÀÖ´Ù.
  
  ½ÉÀåÀÇ 2°³ÀÇ ½É¹æ°ú 2°³ÀÇ ½É½Ç, ±×¸®°í ½É¹æ»çÀÌÀÇ ½É¹æÁß°Ý, ½É½Ç»çÀÌÀÇ ½É½ÇÁß°ÝÀÌ Á¸ÀçÇÑ´Ù. ½É½ÇÀº Ç÷¾×À» ÁַΠ¼øÈ¯½Ã۴ ÈûÀ» ³»´Â °÷À¸·Î °­ÇÑ ±ÙÀ°ÃþÀÌ Á¸À縦 ÇÑ´Ù. ¹Ý¸é¿¡ ½É¹æÀº ½É½Ç¿¡ µé¾î°¡±âÀü¿¡ ÀϽÃÀûÀ¸·Î Çǰ¡ ¸ðÀ̴ °÷À¸·Î ±ÙÀ°ÃþÀÇ ¹ß´ÞÀÌ ¹Ì¾àÇÏ´Ù. ½É¹æ°ú ½É½Ç»çÀÌ¿¡ »ï÷ÆÇ°ú ½Â¸ðÆÇ, ½É½ÇÀÇ À¯Ãâ·Î¿¡ ´ëµ¿¸ÆÆÇ°ú Æóµ¿¸ÆÆÇÀÌ ÀÖ´Ù. À̰͵éÀº Ç÷¾×ÀÌ È帣´Â ¹æÇâ¿¡ °Å½½·¯ ÁøÇàÇϴ °ÍÀ» ¸·´Â ±â´ÉÀ» ÇÑ´Ù. ±×¸®°í ½ÉÀå¿¡´Â ½ÉÀåÀÇ ±ÙÀ°¿¡ Ç÷¾×À» °ø±ÞÇϴ °ü»óµ¿¸ÆÀÌ ÀÖ´Ù. ÀÌ ½ÉÀ嵿¸ÆÀº ½ÉÀåÀ» ½×µíÀÌ Á¸ÀçÇÑ´Ù.
  
  ½ÉÀå¹Úµ¿ÀÇ ½ÅÈ£´Â Æ¯¼öÇÑ ÀåÄ¡¿¡ ÀÇÇØ¼­ ¹ß»ýÀÌ µÇ°í Æ¯¼öÇÑ Àüµµ°è¸¦ ÅëÇØ¼­ ÀüüÀÇ ½ÉÀåÀ¸·Î ÀüµµµÈ´Ù. ½ÉÀå¹Úµ¿ÀÇ ½ÅÈ£´Â ¿ì¼± ¿ì½É¹æ¿¡ À§Ä¡Çϴ µ¿¹æ°áÀý(SA node)¶ó´Â °÷¿¡¼­ ¿ì¼± »ý±ä´Ù. ¿©±â¿¡¼­ º¸³»´Â Àü±âÀû ½ÅÈ£°¡ ¹Ù·Î ½ÉÀåÀ» ¶Ù°ÔÇϴ ½ÅÈ£ÀΠ°ÍÀÌ´Ù. ÀÌ ½ÅÈ£·Î ¸»¹Ì¾Ï¾Æ ½É¹æÀÌ ¿ì¼± ¼öÃàÀ» ÇÑ´Ù. ±×¸®°í´Â ½É¹æ°ú ½É½Ç»çÀÌ¿¡ À§Ä¡Çϴ ¹æ½Ç°áÀý(AV node)¶ó´Â °÷¿¡ ÀÏÁ¤ÇϰԠÁ¤ÇØÁø Åë·Î¾øÀÌ ÀüüÀÇ ½É¹æÀ» ÅëÇØ¼­ Àü´ÞÀÌ µÇ°í ÀÌ ½ÅÈ£¸¦ ¹ÞÀº ¹æ½Ç°áÀý(AV node)´Â È÷½º ´Ù¹ß(His bundle)°ú ½ÉÀåÀüµµ±ÙÀ°¼¶À¯¸¦ ÅëÇØ¼­ ½É½ÇÀÇ ½ÉÀå±ÙÀ°¿¡°Ô ÀÌ ½ÅÈ£¸¦ º¸³»Á־ɽDZÙÀ°À» ¼öÃàÇϰԠÇÑ´Ù. È÷½º´Ù¹ß°ú ½ÉÀåÀüµµ±ÙÀ°¼¶À¯´Â ÀüüÀÇ ½É½ÇÀÇ ½É±Ù¼¶À¯¿¡ µ¿½Ã¿¡ Àü±âÀû ½ÅÈ£¸¦ º¸³»¾î ÁÙ ¼ö ÀÖ°Ô Çϴ ÀÏÁ¾ÀÇ Àü±âÁÙ°ú °°Àº ¿ªÇÒÀ» ÇÑ´Ù.
  
  ½ÉÀå
¿µ¹® heart failure ÇÑ±Û ½ÉÀå±â´É»ó½Ç
¼³¸í   
  ¸öÀÇ Á¶Á÷À̳ª ±â°ü¿¡¼­ ´ë»ç¿¡ ÇÊ¿äÇÑ ¸¸Å­ ÃæºÐÇÑ ¾çÀÇ Ç÷¾×À» °ø±ÞÇÒ ¼ö ¾øÀ» Á¤µµ·Î ½ÉÀå±â´ÉÀÌ ÀúÇϵǾî Àִ »óÅÂÀÌ´Ù. ½ÉÀå±â´É»ó½ÇÀº ½É±ÙÀÌ ¼öÃàÇÒ ´É·ÂÀÌ ÀúÇϵǾúÀ» ¶§³ª ½ÉÀå¿¡ ½É¹ÚÃâÀ» Çϱâ À§ÇÑ ¾Ð·ÂÀÌ Á¤»óº¸´Ù Áõ°¡µÇ¾î Á¤»óÀÇ ½ÉÀåÀÇ ¼öÃàÀ¸·Î´Â ÃæºÐÇÑ ¾çÀÇ Ç÷¾×À» °ø±ÞÇÒ ¼ö ¾ø´Â °æ¿ì, ±×¸®°í ½ÉÀå±ÙÀ°, ½ÉÀå¿¡ °É¸®´Â ¾Ð·ÂÀº Á¤»óÀ̳ª ½ÉÀå¹Úµ¿ÀÇ À̻󿡠ÀÇÇØ¼­ Á¤»óÀûÀΠ¼öÃàÀÌ ºÒ°¡´ÉÇÒ °æ¿ì¿¡ »ý±ä´Ù.
¿µ¹® pacemaker(of heart) ÇÑ±Û ½ÉÀå¹Úµ¿±â
¼³¸í   
  ½ÉÀåÀÇ Àü±âÀû ÀÚ±ØÀÌ º´ÀûÀΠ»óÅ·Π¹ß»ýÇÏÁö ¾Ê°Å³ª, È¤Àº ½É½Ç·Î Àß ÀüÇØÁöÁö ¾ÊÀ» ¶§ »ç¿ëÇÑ´Ù. ÀϽÃÀû ½ÉÀå¹Úµ¿±â¿Í ¿µ±¸Àû ½ÉÀå¹Úµ¿±â°¡ ÀÖÀ¸¸ç, °¢±â ¾²À̴ ¿ëµµ´Â º´¿¡ µû¶ó ´Ù¸£´Ù.
  
  ¿äÁò¿¡ ³ª¿À´Â ½ÉÀå ¹Úµ¿±â´Â °ÇÀüÁöÀÇ ¼ö¸íµµ ¹Ý¿µ±¸ÀûÀ̸ç, ¹Û¿¡¼­ Á¶Á¤ÇÒ ¼ö ÀÖ°í, ¿îµ¿À̳ª ½ºÆ®·¹½º »óȲ¿¡ ´ëÇÑ ½ÉÀåÀÇ ºü¸¥ ¿îµ¿¿¡µµ Àß ÀûÀÀÇÒ ¼ö ÀÖµµ·Ï ¸¸µé¾îÁ® ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • maximum compliance
    ÃÖ´ë¼øÀÀµµ
  • maximum dose
    1. ÃÖ´ë¿ë·® 2. ÃÖ´ë¼±·®
  • maximum gradient strength
    ÃÖ´ë±â¿ï±â¼¼±â, ÃÖ´ë°æ»ç°­µµ
  • maximum intensity projection
    ÃÖ´ë°­µµÅõ»ç
  • maximum midexpiratory flow
    ÃÖ´ëÁß°£³¯¼ûÀ¯·®, ÃÖ´ëÁß°£È£±âÀ¯·®
  • maximum oxygen debt
    ÃÖ´ë»ê¼ÒºÎä
  • maximum permissible concentration
    ÃÖ´ëÇã¿ë³óµµ
  • maximum permissible level
    ÃÖ´ëÇã¿ë¼öÁØ
  • maximum permissible limit
    ÃÖ´ëÇã¿ëÇѰè
  • maximum phonation time
    ÃÖÀå¹ß¼ºÁö¼Ó½Ã°£
  • maximum power output
    ÃÖ´ëÃâ·Â
  • maximum safe intensity level
    ÃÖ´ë¾ÈÀü°­µµ¼öÁØ
  • maximum security unit
    ÃÖ´ë¾ÈÀüº´µ¿
  • maximum tolerance dose
    1. ÃÖ´ë³»¾à¿ë·®, ÃÖ´ë³»¾à·® 2. ÃÖ´ë°ßµõ¼±·®
  • maximum urea clearance
    ÃÖ°í¿ä¼Òû¼Ò, ÃÖ°í¿ä¼Òû¼ÒÀ²
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • adjusted death rate
    (¢¡standardized death rate) Ç¥ÁØÈ­»ç¸Á·ü
  • alveolar ventilation rate
    ÇãÆÄ²Ê¸®È¯±âÀ², ÆóÆ÷ȯ±âºñ
  • attack rate
    ¹ßº´·ü
  • basal metabolic rate
    ±âÃÊ´ë»çÀ²
  • birth rate
    Ãâ»ý·ü
  • blood flow rate
    Ç÷·ù·®, Ç÷·ù¼Óµµ
  • cardiac rate
    (¢¡heart rate) ½ÉÀå¹Úµ¿¼ö
  • case fatality rate
    Ä¡¸í·ü
  • case morbidity rate
    Áõ·ÊÀÌȯÀ²
  • crude birth rate
    ÀϹÝÃâ»ý·ü, Á¶Ãâ»ý·ü
  • crude death rate
    ÀϹݻç¸Á·ü, Á¶»ç¸Á·ü
  • erythrocyte sedimentation rate
    ÀûÇ÷±¸Ä§°­¼Óµµ, Ç÷ħ¼Óµµ
  • fatality rate
    Ä¡¸í·ü
  • fertility rate
    »ý½Ä·ü, ¼öÅÂÀ²
  • fetal death rate
    žƻç¸Á·ü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • maximum midexpiratory flow
    Ãִ볯¼ûÁß°£À¯·®
  • maximum acceptable daily intake
    ÀÏÀϼ·ÃëÃÖ´ëÇã¿ë·®
  • maximum allowable limit
    ÃÖ´ëÇã¿ëÇѰè
  • maximum permissible level
    ÃÖ´ëÇã¿ë¼öÁØ
  • maximum permissible limit
    ÃÖ´ëÇã¿ëÇѰè
  • maximum safe intensity level
    ÃÖ´ë¾ÈÀü°­µµ¼öÁØ
  • maximum
    ÃÖ´ë
  • maximum transport
    ÃÖ´ë¿î¹ÝÄ¡, ÃÖ´ëÀ̵¿Ä¡
  • maximum allowable value
    ÃÖ´ëÇã¿ëÄ¡
  • maximum articulation score
    ÃÖ°í¸í·áµµ
  • maximum cardiac output
    ÃÖ´ë½ÉÀå¹ÚÃâ·®
  • maximum discrimination score
    ÃÖ´ë¸í·áµµ
  • maximum gradient strength
    ÃÖ´ë°æ»ç¼¼±â, ÃÖ´ë±â¿ï±â¼¼±â
  • maximum intensity projection
    ÃÖ´ë°­µµÅõ»ç
  • maximum phonation time
    ÃÖÀå¹ß¼ºÁö¼Ó½Ã°£
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • MVR=£¾maximus voiding rate
    ÃÖ´ë¹è´¢À².
  • Westergren sedimentation rate
    ¿þ½ºÅͱ׷»Ä§°­¼Óµµ
  • absorbed dose rate
    Èí¼ö¼±·®À²
  • actual death rate
    ½ÇÁ¦»ç¸Á·ü(ËàÌ¡Ë×ËÎËô).
  • adjusted death rate
    Á¶Á¤»ç¸Á·ü.
  • age specific death rate
    ¿¬·Éº° »ç¸Á·ü
  • air kerma-rate constant
    °ø±âÄ¿¸¶À²»ó¼ö
  • alveolar ventilation rate
    ÆóÆ÷ȯ±âºñ(¡­üµÑ¨Ýï)
  • arterial perfusion rate
    µ¿¸Æ°ü·ùÀ²
  • fractional fibrinogen catabolic rate
    ºÐȹº° ¼¶À¯¼Ò¿ø ´ë»çÀ².
  • frame rate
    È­¸éÀ²
  • frame rate
    È­¸é ¹ß»ýÀ² (ûþØü Û¡ßæëÒ)
  • general fertility rate
    ÀϹÝÃâ»êÀ².
  • general fertility rate
    ÀϹÝÃâ»êÀ².
  • glomerular filtration rate
    »ç±¸Ã¼ ¿©°úÀ²
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • maximum acceptable daily intake =MADI
    ÀÏÀϼ·ÃëÃÖ´ëÇã¿ë·®(ËöËöËÛ̧̬ËÀÌ´ËíËâ).
  • maximum acid output
    ÃÖ´ë»ê¹èÃâ·®
  • maximum acid output
    ÃÖ´ë»êºÐºñ·®(õÌÓÞß«ÝÂù²åÖ).
  • maximum allowable concentration =MAC
    ÃÖ´ëÇã¿ë³óµµ(õÌÓÞúÉé»ÒØöô).
  • maximum allowable dose =MAD
    ÃÖ´ë Çã¿ë·®(¡­úÉé»åÖ).
  • maximum allowable dose =MAD
    ÃÖ´ëÇã¿ë·®(¡­úÉé»åÖ).
  • maximum allowable limit
    ÃÖ´ëÇã¿ëÇѰè(¡­ùÚÍ£).
  • maximum allowable value
    ÃÖ´ëÇã¿ëÄ¡.
  • maximum and minimum thermometer
    ÃÖ°í ÃÖÀú¿Âµµ°è(õÌÍÔõÌî¸è®öôͪ).
  • maximum and minimum thermometer
    ÃÖ°í ÃÖÀú¿Âµµ°è(Ì§Ë­Ì§ËøËí̬˭).
  • maximum articulation score
    ÃÖ°í¸í·áµµ
  • maximum breathing capacity =MBC
    ÃÖ´ëÈ£Èí(¿ë)·®(õÌÓÞû¼ýåé»åÖ), ÃÖ´ëȯ ±â
  • maximum cardiac output
    ÃÖ´ë½É¹ÚÃâ·®(õÌÓÞãýÚÑõóåÖ).
  • maximum compliance
    ÃÖ´ë¼øÀÀµµ
  • maximum discrimination score
    ÃÖ´ë¸í·áÄ¡
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • rate zonal centrifugation
    ¼Óµµ ±¸¿ª ¿ø½ÉºÐ¸®(áÜÓøÏ¡æ´êÀãýÝÂ×î)
  • mutation rate
    º¯ÀÌÀ²(ܨì¶ëÒ)
  • reaction rate
    ¹ÝÀÀ ¼Óµµ·Ð(ÚãëëáÜÓøÖå)
  • specific growth rate
    ºñ¼ºÀåÀ²(Ýïà÷íþëÒ)
  • specific rate constant
    ƯÀÌ ¼Óµµ»ó¼ö(÷åì¶áÜÓøßÈâ¦)
  • specific reaction rate
    ƯÀÌ ¹ÝÀÀ¼Óµµ(÷åì¶ÚãëëáÜÓø)
  • transfer rate coefficient
    ÀüÀÌ ¼Óµµ °è¼ö(ï®ì¹áÜÓøÌõâ¦)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • respiration rate
    È£Èí·ü
  • specific absorption rate [=SAR]
    ƯÀÌÈí¼öÀ²
  • turnover rate
    ±³Ã¼À², ±³Ã¼¼Óµµ, ±³´ëÀ²
  • acquired heart disease
    ÈÄõ¼º½ÉÀåÁúȯ
  • apex of heart
    ½É÷
  • base of heart
    ½ÉÀúºÎ
  • coronary heart disease
    °ü»óµ¿¸Æ½ÉÁúȯ
  • cyanotic heart disease
    û»ö¼º½ÉÀåÁúȯ
  • heart
    ½ÉÀå
  • heart beat
    ½É¹Úµ¿
  • heart block
    ½ÉÂ÷´Ü
  • heart catheterization
    ½ÉÀåÄ«Å×Å׸£¹ý
  • heart failure
    ½ÉºÎÀü
  • heart lung machine
    ½ÉÆó±â, Àΰø½ÉÆóÀåÄ¡±â
  • heart lung ratio
    ½ÉÆó°è¼ö
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MDHR maximum determined heart rate
PMHR predicted maximum heart rate
MMFR maximum midexpiratory flow rate; maximal midflow rate
MPR mannose 6-phosphate receptor; marrow production rate; massive preretinal retraction; maximum pulse r...
MRR marrow release rate; maximum relation rate
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HRV Heart rate variation
IHR Instantaneous Heart Rate
IHR Intrinsic heart rate
MHR Maternal heart rate
MHR Maximal heart rate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • maximum oxygen consumption
    ÃÖ´ë »ê¼Ò ¼Ò¸ð·®
  • maximum permissible concentration
    ÃÖ´ë Çã¿ë ³óµµ
  • maximum permissible exposure
    ÃÖ´ë Çã¿ë ³ëÃâ
  • maximum permissible limit
    ÃÖ´ë Çã¿ë ÇѰè
  • maximum point of opening
    ÃÖ´ë °³±¸À§
  • maximum rotation of the joint
    °üÀýÀÇ ÃÖ´ë ȸÀü ¿îµ¿·®
  • maximum security unit
    ÃÖ´ë ¾ÈÀü º´µ¿
  • maximum surgical blood order schedule
    ÃÖ´ë ¼ö¼ú Ç÷¾× ¿äû ¿¹Á¤Ç¥
  • maximum tolerance dose
    ÃÖ´ë ³»¿ë·®, ÃÖ´ë °ßµõ ¼±·®
  • maximum urethral closure pressure
    ÃÖ°í ¿äµµ Æó¼â¾Ð
  • maximum vapor tension
    ÃÖ´ë Áõ±â Àå·Â
  • acquired heart disease
    ÈÄõ¼º ½É Áúȯ
    »ýÈÄ¿¡ ¾ò¾îÁø ½ÉÀå Áúȯ.
  • acute heart failure
    ±Þ¼º ½ÉºÎÀü
    ±Þ¼º ¼øÈ¯ ºÎÀüÀÇ ÇϳªÀÌ°í ¿øÀÎÀÌ ½ÉÀå¿¡ ÀÖÀ» ¶§¸¦ ¸»ÇÑ´Ù. ±Þ¼º Á½ɺÎÀüÀº °íÇ÷¾Ð, ´ëµ¿¸ÆÆÇ ¹× ½Â¸ðÆÇ¸·Áõ, ½É±Ù¿°, Ư¹ß¼º ½É±ÙÁõ µî¿¡ À־ Á½ɽǿ¡ °©Àڱ⠻ý±ä ¼öÃà ºÎÀüÀ¸·Î ÀÎÇØ¼­ »ý±â´Â °ÍÀ̰í, Æó ¿ïÇ÷À» °¡Á®¿Í ¹ßÀÛ¼º È£Èí°ï¶õÀÌ »ý±ä´Ù. ±Þ¼º ¿ì½ÉºÎÀüÀº ±Þ¼º Æó»öÀü, ½É±Ù¿° µî¿¡ ÀÇÇØ ¿ì½ÉÀÇ ±Þ¼º ¼öÃà ºÎÀüÀÌ »ý°åÀ» ¶§¿¡ ÀÏÀ¸Å°°í ¿ì½ÉÀ¸·ÎÀÇ È¯·ù °¨¼Ò·Î ÀÎÇØ¼­ Ç÷¾ÐÀúÇÏ, ¼îÅ©°¡ »ý±ä´Ù. È£Èí°ï¶õ, ºóÈ£ÈíÀ» ³ªÅ¸³»±âµµ ÇÑ´Ù.
  • American Heart Association
    ¹Ì±¹½ÉÀ庴ÇÐȸ, ¹Ì±¹½ÉÀåÇÐȸ
  • apex of heart
    ½ÉÀ峡, ½É÷ºÎ, ½É÷
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
tubular maximum transport maximum
abortion rate The number of abortions per 1000 terminated pregnancies during a given period of time.
(05 Mar 2000)
age-specific rate A rate for a specified age group, in which the numerator and denominator refer to the same age group.
(05 Mar 2000)
attack rate A cumulative incidence rate used for particular groups observed for limited periods under special circumstances, such as during an epidemic.
(05 Mar 2000)
average flow rate <physiology> The flow rate determined by dividing the total volume passed in a time period divided by the time period, usually quoted in mls per minute.
(05 Mar 2000)
backup rate A utility charge for providing occasional electricity service to replace on-site generation.
(05 Dec 1998)
basal metabolic rate <biochemistry, biology> The metabolic rate as measured under basal conditions: 12 hours after eating, after a restful sleep, no exercise or activity preceding test, elimination of emotional excitement and occurring in a comfortable temperature.
Acronym: BMR
(15 Nov 1997)
basic reproductive rate, ratio <epidemiology> See Reproductive Ratio.
(05 Dec 1998)
birth rate The birth rate is usually given as the number of live births divided by the average population (or the population at midyear). This is termed the crude birth rate. In 1995, for example, the crude birth rate per 1,000 population was 14 in the United States, 16.9 in Australia, etc.
(12 Dec 1998)
breathing rate <chest medicine, clinical sign> Also referred to as the respiratory rate.
Measured as the number of breaths taken every minute. Normal resting adult respiratory rates are from 16-20 breaths per minute.
The normal 1 year old infant can have a respiratory rate of 30 breaths per minute. Count the breaths taken in 30 seconds observing the rise and fall of the chest and then multiply this number by 2.
(27 Sep 1997)
rate The number of occurrences in one minute (for example respiratory rate, heart rate)
(27 Sep 1997)
rate, basal metabolic A measure of the rate of metabolism. For example, someone with an overly active thyroid will have an elevated basal metabolic rate.
(12 Dec 1998)
rate, birth The birth rate is usually given as the number of live births divided by the average population (or the population at midyear). This is termed the crude birth rate. In 1995, for example, the crude birth rate per 1,000 population was 14 in the united states, 16.9 in Australia, etc.
(12 Dec 1998)
rate constants Proportionality constants equal to the initial rate of a reaction divided by the concentration of the reactant(s); e.g., in the reaction A &rarr; B + C, the rate of the reaction equals -d[A]/dt = k1[A]. The rate constant k1 is a unimolecular rate constant since there is only one molecular species reacting and has units of reciprocal time (e.g., sec-1). For the reverse reaction, B + C &rarr; A, the rate equals -d[B]/dt = d[A]/dt = k2[B][C]. The rate constant k2 is a bimolecular rate constant and has units of reciprocal concentration-time (e.g., m-1 sec-1).
Synonym: velocity constants.
(05 Mar 2000)
rate, death The number of deaths in the population divided by the average population (or the population at midyear) is the crude death rate. In 1994, for example, the crude death rate per 1,000 population was 8.8 in the united states, 7.1 in Australia, etc. A death rate can also be tabulated according to age or cause.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Purple Heart
    ¸í¿¹ »óÀ̱âÀå;(ÇÏÆ®Çü)ÈïºÐÁ¦
  • bleeding heart
    ±Ý³¶È­
  • heart
    ½ÉÀå;°¡½¿(¼Ó);¸¶À½;¸¶À½¼Ó;º»½É;¾ÖÁ¤;¿ë±â;±â·Â;¿ø±â;Áß½É;Áß¾Ó;ÇÙ½É
  • heart attack
    =HEART FAILURE
  • heart cherry
    ¾ÞµÎÀÇ ÀÏÁ¾(½ÉÀå ¸ð¾çÀÇ)
  • heart disease
    ½ÉÀ庴
  • heart disease
    ½ÉÀ庴
  • heart failure
    ½ÉÀ帶ºñ;½ÉÀå¹ßÀÛ
  • heart murmur
    ½ÉÀå ÀâÀ½
  • heart transplant
    ½ÉÀåÀ̽Ä
  • heart transplat
    ½ÉÀåÀ̽Ä
  • heart's blood
    ½ÉÀå³»ÀÇ Ç÷¾×;½ÉÇ÷;»ý¸í;Áø½É;»ý¸í·Â;¼ÒÁßÇÑ °Í
  • heartsease,heart'sease
    ¸¶À½ÀÇ ÆòÈ­;¾È½É;»ï»öÁ¦ºñ²É
  • irritable heart
    (º´¸®)°ú¹Î½ÉÀå
  • lonely heart
    (°áÈ¥ »ó´ë¸¦ ¾òÁö ¸øÇÑ) °íµ¶ÇÑ ¿©ÀÚ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á